Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,685Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Risperdal

02 1Risperdal Consta

03 2Risperdal Consta

04 5Risperdal Consta

PharmaCompass

01

Brand Name : Risperdal Consta

Risperidone

arrow
Compamed
Not Confirmed

Brand Name : Risperdal Consta

arrow
Compamed
Not Confirmed

Risperidone

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 642

2019 Revenue in Millions : 688

Growth (%) : -7

blank

02

Brand Name : Risperdal Consta

Risperidone

arrow
Compamed
Not Confirmed

Brand Name : Risperdal Consta

arrow
Compamed
Not Confirmed

Risperidone

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 592

2020 Revenue in Millions : 642

Growth (%) : -8

blank

03

Brand Name : Risperdal Consta

Risperidone

arrow
Compamed
Not Confirmed

Brand Name : Risperdal Consta

arrow
Compamed
Not Confirmed

Risperidone

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 485

2021 Revenue in Millions : 592

Growth (%) : -18

blank

04

Brand Name : Risperdal

Risperidone

arrow
Compamed
Not Confirmed

Brand Name : Risperdal

arrow
Compamed
Not Confirmed

Risperidone

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : -9.70%

2013 Revenue in Millions :

Growth (%) :

blank

05

Brand Name : Risperdal Consta

Risperidone

arrow
Compamed
Not Confirmed

Brand Name : Risperdal Consta

arrow
Compamed
Not Confirmed

Risperidone

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 1,190

2014 Revenue in Millions : 970

Growth (%) : -18%

blank

06

Brand Name : Risperdal Consta

Risperidone

arrow
Compamed
Not Confirmed

Brand Name : Risperdal Consta

arrow
Compamed
Not Confirmed

Risperidone

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 893

2015 Revenue in Millions : 970

Growth (%) : -8

blank

07

Brand Name : Risperdal Consta

Risperidone

arrow
Compamed
Not Confirmed

Brand Name : Risperdal Consta

arrow
Compamed
Not Confirmed

Risperidone

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 805

2016 Revenue in Millions : 893

Growth (%) : -10

blank

08

Brand Name : Risperdal Consta

Risperidone

arrow
Compamed
Not Confirmed

Brand Name : Risperdal Consta

arrow
Compamed
Not Confirmed

Risperidone

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 737

2017 Revenue in Millions : 805

Growth (%) : -8%

blank

09

Brand Name : Risperdal Consta

Risperidone

arrow
Compamed
Not Confirmed

Brand Name : Risperdal Consta

arrow
Compamed
Not Confirmed

Risperidone

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 688

2018 Revenue in Millions : 737

Growth (%) : -7

blank